J. Warren Huff

2021

In 2021, J. Warren Huff earned a total compensation of $4M as Chief Executive Officer and Chairman of the Board at REATA PHARMACEUTICALS, a 37% decrease compared to previous year.

Compensation breakdown

Option Awards$3,389,373
Salary$636,400
Other$6,000
Total$4,031,773

Huff received $3.4M in option awards, accounting for 84% of the total pay in 2021.

Huff also received $636.4K in salary and $6K in other compensation.

Rankings

In 2021, J. Warren Huff's compensation ranked 3,326th out of 12,406 executives tracked by ExecPay. In other words, Huff earned more than 73.2% of executives.

ClassificationRankingPercentile
All
3,326
out of 12,406
73rd
Division
Manufacturing
1,352
out of 5,494
75th
Major group
Chemicals And Allied Products
550
out of 2,369
77th
Industry group
Drugs
489
out of 2,090
77th
Industry
Pharmaceutical Preparations
337
out of 1,537
78th

Pay ratio

J. Warren Huff's Pay$4,031,773
Median Employee's Pay$244,581
Pay Ratio

16

to 1

In 2021, the annual total compensation of J. Warren Huff was $4,031,773.

The annual total compensation of the median employee at REATA PHARMACEUTICALS was $244,581.

The ratio of J. Warren Huff's pay to the pay of median employee was therefore 16 to one.

Source: SEC filing on April 29, 2022.

Huff's colleagues

We found four more compensation records of executives who worked with J. Warren Huff at REATA PHARMACEUTICALS in 2021.

2021

Manmeet Soni

REATA PHARMACEUTICALS

Chief Financial Officer

2021

Colin Meyer

REATA PHARMACEUTICALS

Chief Innovation Officer and Executive Vice President

2021

Dawn Bir

REATA PHARMACEUTICALS

Chief Commercial Officer and Executive Vice President

2021

Michael Wortley

REATA PHARMACEUTICALS

Chief Legal Officer

News

In-depth

You may also like